Advertisement
Research Article Pharmacokinetics, Pharmacodynamics and Drug Transport and Metabolism| Volume 110, ISSUE 6, P2562-2569, June 01, 2021

Predicting Oral Absorption for Compounds Outside the Rule of Five Property Space

Published:February 01, 2021DOI:https://doi.org/10.1016/j.xphs.2021.01.029

      Abstract

      The estimation of the extent of absorption of drug candidates intended for oral drug delivery is an important selection criteria in drug discovery. The use of cell-based transwell assays examining flux across cell-monolayers (e.g., Caco-2 or MDCK cells) usually provide satisfactory predictions of the extent of absorption in vivo. These predictions often fall short of expection for molecules outside the traditional low molecular weight property space. In this manuscript the transwell permeability assay was modified to circumvent potential issues that can be encountered when evaluating the aforementioned drug molecules. Particularly, the addition of albumin in the acceptor compartment to reduce potential binding to cells and the acceptor compartment, improved the predictive power of the assay. Cellular binding and lysosomal trapping effects are significantly reduced for larger molecules, particularly lipophilic bases under these more physiological conditions, resulting in higher recovery values and a better prediction power. The data indicate that lysosomal trapping does not impact the rate of absorption of lipophilic bases in general but is rather an exception. Finally, compounds believed to permeate by passive mechanisms were used in a calibration curve for the effective prediction of the fraction absorbed of molecules of interest in current medicinal chemistry efforts.

      Keywords

      To read this article in full you will need to make a payment
      APhA Member Login
      APhA Members, full access to the journal is a member benefit. Use your society credentials to access all journal content and features.
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Purchase one-time access:

      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Egan W.J.
        • Lauri G.
        Prediction of intestinal permeability.
        Adv Drug Deliv Rev. 2002; 54: 273-289
        • Dahlgren D.
        • Roos C.
        • Sjögren E.
        • Lennernäs H.
        Direct in vivo human intestinal permeability (Peff) determined with different clinical perfusion and intubation methods.
        J Pharm Sci. 2015; 104: 2702-2726
        • Maubon N.
        • Le Vee M.
        • Fossati L.
        • et al.
        Analysis of drug transporter expression in human intestinal Caco-2 cells by real-time PCR.
        Fund Clin Pharmacol. 2007; 21: 659-663
      1. Aldrich S MDR1 knockout Caco-2 cells.
        (Available at:)
        • Irvine J.D.
        • Takahashi L.
        • Lockhart K.
        • et al.
        MDCK (Madin–Darby canine kidney) cells: a tool for membrane permeability screening.
        J Pharm Sci. 1999; 88: 28-33
        • Di L.
        • Whitney-Pickett C.
        • Umland J.P.
        • et al.
        Development of a new permeability assay using low-efflux MDCKII cells.
        J Pharm Sci. 2011; 100: 4974-4985
        • Christopher A.
        • Lipinski F.L.
        • Dominy B.W.
        • Feeney P.J.
        Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings.
        Adv Drug Deliv Rev. 1997; 23: 3-25
        • Bednarczyk D.
        • Sanghvi M.V.
        The impact of assay recovery on the apparent permeability, a function of lysosomal trapping.
        Xenobiotica. 2020; 50: 753-760
        • Kazmi F.
        • Hensley T.
        • Pope C.
        • et al.
        Lysosomal sequestration (trapping) of lipophilic amine (cationic amphiphilic) drugs in immortalized human hepatocytes (Fa2N-4 cells).
        Drug Metab Dispos. 2013; 41: 897-905
        • Li J.
        • Dong Z.
        • Wu F.
        • et al.
        Developing a mechanistic absorption model to predict the pharmacokinetics of immediate-release weak base drugs with a long tmax by incorporating lysosomal trapping.
        Drug Metabol Pharmacokinet. 2018; 33: S63-S64
        • Saha P.
        • Kou J.H.
        Effect of bovine serum albumin on drug permeability estimation across Caco-2 monolayers.
        Eur J Pharm Biopharm. 2002; 54: 319-324
        • Tavelin S.
        New Approaches to Studies of Paracellular Drug Transport in Intestinal Epithelial Cell Monolayers.
        Eklundshofs Grafiska, Uppsala2003
        • Adson A.
        • Raub T.J.
        • Burton P.S.
        • et al.
        Quantitative approaches to delineate paracellular diffusion in cultured epithelial cell monolayers.
        J Pharm Sci. 1994; 83: 1529-1536
        • Sugano K.
        • Takata N.
        • Machida M.
        • Saitoh K.
        • Terada K.
        Prediction of passive intestinal absorption using bio-mimetic artificial membrane permeation assay and the paracellular pathway model.
        Int J Pharm. 2002; 241: 241-251
        • Low Y.W.
        • Blasco F.
        • Vachaspati P.
        Optimised method to estimate octanol water distribution coefficient (logD) in a high throughput format.
        Eur J Pharm Sci. 2016; 92: 110-116
        • Ertl P.
        • Rohde B.
        • Selzer P.
        Fast calculation of molecular polar surface area as a sum of fragment-based contributions and its application to the prediction of drug transport properties.
        J Med Chem. 2000; 43: 3714-3717
        • Berben P.
        • Bauer-Brandl A.
        • Brandl M.
        • et al.
        Drug permeability profiling using cell-free permeation tools: overview and applications.
        Eur J Pharm Sci. 2018; 119: 219-233